cancer
Type I Interferon Responses Enhance the Regenerative Activity of Salivary Gland Stem Cells After Radiotherapy
Blockade of IFN-β or RIG-I Attenuates This Effect
Therapeutic Potential of Type I Interferon in Enhancing Sensitivity to Cancer Immunotherapy
Type I Interferon Regulates Metastasis and Improves Tumor Response to Immune Checkpoint Blockade
Pregnancy and Breastfeeding Protect Against Breast Cancer
CD8+ T Cells Provide Antitumor Protection
Ketogenic Diet During Cancer Immunotherapy Boosts Interferon Production
Survival Increases from 42% to 67%
Physical Exercise After Colorectal Cancer Treatment Reduces Recurrence Risk by 28%
Possible Mechanism – Reduced Inflammation and Enhanced Immune Surveillance
mRNA IFN-I Nanoparticles Suppress Lung Metastases
A Candidate for Third-Generation Interferon-Based Cancer Therapy
SLIC-IFN-γ: Bacteria That Help Overcome Resistance to Cancer Immunotherapy
Targeted Delivery of Interferon-γ Enhances the Effect of PD-1 Blockade
Influenza and COVID-19 – Potential Triggers of Cancer Progression
Respiratory Viruses Elevate IL-6 Levels, Activating Dormant Breast Cancer Cells
Interferon Gamma Reduces the Angiogenic Potential of Cancer Cells
IFN-γ Suppresses Perlecan Gene Expression and Tumor Growth
Interferon-Gamma Against Leptomeningeal Metastases
For Antitumor Effect, IFNγ Requires NK Cells
Next-Generation Cancer and Virus Vaccines: The SABER Platform
SABER molecules enhance cross-presentation by improving antigen delivery to the endoplasmic reticulum
PD-L1 Suppresses Interferon Response, Enhancing Oncolytic Virus Efficacy”
Combining oncolytic viruses with PD-1/PD-L1 blockers is a promising cancer treatment strategy
Interferon-gamma suppresses the anti-tumor activity of T cells
Ablation of IFN-γ receptor on CD8+ T cells enhances tumor control
METTL3 Inhibitor Triggers Interferon Response, Enhancing Anti-Tumor Immunity
A combination of METTL3 inhibitor and anti-PD-1 improves cancer survival
Type I Interferons Produced During Viral Infections Suppress Metastasis
RSV Infection Prevents Lung Metastasis Development
IL-27 Enhances Anti-Tumor T Cell Response
IL-27 Improves Cancer Treatment Effectiveness
Aspirin Prevents Metastasis
Aspirin inhibits TXA2 activity, enhancing T-cell activation
NDV-GT – a virus that treats cancer
The oncolytic virus induces a hyperacute rejection response
Lurbinectedin and Atezolizumab for Small-Cell Lung Cancer
Lurbinectedin Enhances IFN Signaling to Boost Immunotherapy Efficacy
New Frontiers in Lung Cancer Treatment: STAT3 and Interferon Therapy
The STAT3-STING-IFN Axis Governs Small-Cell Lung Cancer Metastasis
Interferons in Cancer Immunotherapy
How Interferons Affect Immune Cells and Tumors
Ketogenic Diet: Treatment or Organ Threat?
Prolonged keto diet induces cellular aging, but intermittent improves metabolism
Vitamin D: from Cancer Prevention to Immunotherapy Success
Vitamin D regulates the microbiota balance, enhancing anti-tumor immunity
Quercetin – an Antioxidant with Neuroprotective and Antiviral Properties
Overview of the Therapeutic Effects of Quercetin
Interferon-α Inhibits Melanoma Metastasis
IFN-alpha reduces the ability of cancer stem cells to form tumors
Lacidophilin Improves The Efficacy of Interferon α-2b in Treating Human Papillomavirus
Safe prevention of cervical cancer in HPV patients
Interferon Influences the Effectiveness of Radiotherapy
Radiotherapy triggers an antitumor response when it does not target healthy tissue
Lycopene – An Antioxidant for Vascular and Brain Health
Consumption rate and content in products
Interferon-Alpha-2b Is Effective and Safe to Treat Ocular Surface Squamous Neoplasia
The tumor resolved entirely in 83% of cases.
Interferon And Lactation: Clinical Experience with Interferon-Alpha in Breastfeeding
Does interferon-alpha pass into breast milk?
Physical Activity Suppresses Cancer
During exercise, muscles release molecules that slow down the progression of cancer
Type I Interferons Prevent UV-Induced Skin Cancer
Type I interferons stimulate repair of DNA damage and counter suppression of skin immune
Microbiota to Defeat Cancer: Intestinal Bacteria Regulate The Anti-Cancer Response in The Tumor Microenvironment
Microbiota triggers the production of interferon by monocytes, activating anti-tumor immunity
Type I Interferon Accelerates Liver Regeneration After Injury
The role of interferon in the recovery of hepatocytes and the development of hepatocellular carcinoma
Tumor secretes vesicles that suppress the protective response of interferon
To stop the absorption of tumor vesicles means to block the development of metastases
Type I interferons control obesity and cancer
Dual role of endogenous interferon in the control of tumor growth and obesity
Treatment of follicular lymphoma with tumor injections of dendritic cells treated with interferon-α2b
Clinical trial, Phase 1
Immunotherapy complication: cytokine release syndrome
Blocking the increasing production of catecholamines reduces inflammatory damage and mortality